The company raised its full-year revenue guidance from a range of $58 billion to $61 billion to a range of $60 billion to $62 billion. The midpoint suggests a 35% increase in sales for the full year.

Some of the losses are down to pharma's broader problems: notably, President Trump's tariff and price-cut threats. But there ...

Serena Williams has revealed she lost 31 pounds on the GLP-1 Zepbound: "I just couldn't get my weight to where I needed to be at a healthy place." ...

Tennis champion Serena Williams has divided the internet after revealing she’s been using a GLP-1 weight loss drug. The ...

GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...

Serena Williams has a new doubles partner. The 23-time Grand Slam tennis champion is working with Ro, speaking out about how ...

Serena Williams turned to a weight loss medication and it is paying off massively as the American tennis icon reveals she ...

Tennis star Serena Williams' candor about her GLP-1 use may help dispel the pesky health inaccuracy that weight loss is a simple matter of exercise.

Serena Williams is coming clean about how she lost a dramatic amount of weight. Fans were shocked the other day by Williams’ Instagram selfie, dressed in a tummy baring crop top and Grecian skirt, ...

Serena Williams reveals a 31-pound weight loss with Zepbound after fan concern, crediting the drug for transforming her ...

Serena Williams opens up about hitting a weight loss plateau and why she turned to Zepbound to achieve her fitness goals.

Serena Williams shocked recently when she posted a picture of herself in the gym looking like a completely different person ...